Company Perspective Therapeutics, Inc.
Equities
CATX
US46489V1044
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.58 USD | -1.25% | +5.33% | +293.03% |
Business Summary
Number of employees: 118
Sales per Business
USD in Million | 2023 | Weight | Delta |
---|---|---|---|
Precision-targeted Alpha Therapies
100.0
%
| 1 | 100.0 % | - |
Sales per region
USD in Million | 2023 | Weight | Delta |
---|---|---|---|
United States
100.0
%
| 1 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Johan Spoor
CEO | Chief Executive Officer | 51 | 23-02-02 |
Mark Austin
DFI | Director of Finance/CFO | 37 | - |
Jonathan Hunt
DFI | Director of Finance/CFO | 57 | 23-02-02 |
Markus Puhlmann
CTO | Chief Tech/Sci/R&D Officer | - | - |
Andrew Bright
PRN | Corporate Officer/Principal | - | 23-04-02 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Heidi Henson
BRD | Director/Board Member | 58 | 23-05-31 |
Lori Woods
CHM | Chairman | 62 | 23-02-02 |
Director/Board Member | 58 | 23-02-02 | |
Johan Spoor
CEO | Chief Executive Officer | 51 | 23-02-02 |
Frank Morich
BRD | Director/Board Member | 69 | 23-02-02 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 587,195,493 | 449,696,880 ( 76.58 %) | 0 | 76.58 % |
Company contact information
Perspective Therapeutics, Inc.
2401 Elliott Avenue Suite 320
98121, Seattle
+
http://perspectivetherapeutics.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+293.03% | 927M | |
-2.31% | 187B | |
-3.20% | 106B | |
-5.04% | 66.9B | |
+0.20% | 49.45B | |
+17.29% | 48B | |
+4.06% | 40.84B | |
+2.07% | 26.48B | |
+2.36% | 26.25B | |
+12.96% | 24.62B |
- Stock Market
- Equities
- CATX Stock
- Company Perspective Therapeutics, Inc.